tau 284 has been researched along with Cancer of Ovary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, T; Gao, Q; Jin, P; Li, H; Li, X; Wang, SY; Wang, Z; Xia, Y; Xiong, X; Xu, C; Xu, S; Yang, ZY; Zhou, D | 1 |
1 other study(ies) available for tau 284 and Cancer of Ovary
| Article | Year |
|---|---|
Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-κB-Triggered SASP in Cancer-Associated Fibroblasts.
Topics: Cancer-Associated Fibroblasts; Cellular Senescence; Female; Fibroblasts; Humans; NF-kappa B; Ovarian Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Tumor Microenvironment | 2023 |